Miracle

Miracle identified a critical bottleneck in clinical trial operations: biopharmaceutical companies were drowning in fragmented data spread across incompatible systems. ​​‌‌‌‌‌‌‌​‌‌​​‌​​​​​​‌‌​‌‌‌​​​‌‌Trial sponsors and contract research organizations (CROs) experienced this most acutely—they manually aggregated information from electronic data capture systems, laboratory databases, and patient management platforms, a process consuming weeks and introducing errors. The problem was measurably severe: clinical trials cost $2.6 billion on average, with delays costing sponsors $100,000+ daily. Trial managers could quantify lost time spent in spreadsheets rather than decision-making. Existing alternatives—custom dashboards, manual reporting, and consultant-driven analysis—remained slow and reactive. Early validation came when Miracle's initial conversations with trial sponsors revealed unanimous frustration with data latency; sponsors reported making critical enrollment and safety decisions based on week-old information. CROs immediately recognized the operational efficiency gains, confirming that real-time consolidation addressed their most painful workflow bottleneck.